General Information of the Compound
Compound ID |
CP0429946
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
Efatutazone
Show/Hide
|
||||||||||||||||||
Synonyms |
223132-37-4
4CA-1384
5-[4-[6-(4-amino-3 ,5-dimethylphenoxy)-1-methyl-1H-benzimidazol-2-ylmethoxy]benzyl]thiazolidine-2,4-dione
5-[[4-[[6-(4-amino-3,5-dimethylphenoxy)-1-methyl-1H-benzimidazol-2-yl]methoxy]phenyl]methyl]-2,4-Thiazolidinedione
AKOS030526729
BCP07478
CHEMBL3545280
CS-0778
CS-7017
DA-07988
DB11894
Efatutazone
Efatutazone [INN]
Efatutazone;CS-7017;RS5444
FT-0737589
HY-14792
Inolitazone
JCYNMRJCUYVDBC-UHFFFAOYSA-N
KB-77905
PMID25416646-Compound-Figure2-I
QC-10456
RS5444
SCHEMBL3246054
Thiazolidine dione crystalline derivative 1
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C27H26N4O4S
|
||||||||||||||||||
Molecular Weight |
502.596
|
||||||||||||||||||
Canonical SMILES |
Cc1cc(Oc2ccc3nc(COc4ccc(CC5SC(=O)NC5=O)cc4)n(C)c3c2)cc(C)c1N
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C27H26N4O4S/c1-15-10-20(11-16(2)25(15)28)35-19-8-9-21-22(13-19)31(3)24(29-21)14-34-18-6-4-17(5-7-18)12-23-26(32)30-27(33)36-23/h4-11,13,23H,12,14,28H2,1-3H3,(H,30,32,33)
Show/Hide
|
||||||||||||||||||
InChIKey |
JCYNMRJCUYVDBC-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
223132-37-4
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound
Drug 1 ( Thiazolidine dione crystalline derivative 1 )
Drug Name | Thiazolidine dione crystalline derivative 1 | ||
---|---|---|---|
Company | Daiichi Sankyo Co., Ltd | ||
Target(s) |